A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults

Infection ◽  
2018 ◽  
Vol 47 (1) ◽  
pp. 105-109 ◽  
Author(s):  
Micha Loebermann ◽  
Carlos Fritzsche ◽  
Hilte Geerdes-Fenge ◽  
Esther Heijnen ◽  
Daniel Kirby ◽  
...  
Keyword(s):  
Cell Culture ◽  
Influenza Virus ◽  
Mammalian Cell ◽  
Surface Antigen ◽  
Virus Vaccine ◽  
Mammalian Cell Culture ◽  
Influenza Virus Vaccine ◽  
Healthy Adults ◽  
Phase Iii ◽  
Open Label

scholarly journals An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults

Vaccine ◽  
2011 ◽  
Vol 29 (17) ◽  
pp. 3144-3148 ◽  
Author(s):  
Kawsar R. Talaat ◽  
Ruth A. Karron ◽  
Catherine J. Luke ◽  
Bhagvanji Thumar ◽  
Bridget A. McMahon ◽  
...  
Keyword(s):  
Influenza Virus ◽  
Phase I ◽  
Virus Vaccine ◽  
Phase I Trial ◽  
Influenza Virus Vaccine ◽  
Healthy Adults ◽  
Open Label ◽  
Open Label Phase

scholarly journals An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults

2012 ◽  
Vol 7 (1) ◽  
pp. 66-73 ◽  
Author(s):  
Kawsar R. Talaat ◽  
Ruth A. Karron ◽  
Philana H. Liang ◽  
Bridget A. McMahon ◽  
Catherine J. Luke ◽  
...  
Keyword(s):  
Influenza Virus ◽  
Phase I ◽  
Virus Vaccine ◽  
Phase I Trial ◽  
Influenza Virus Vaccine ◽  
Healthy Adults ◽  
Open Label ◽  
Open Label Phase

scholarly journals A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults

Vaccine ◽  
2009 ◽  
Vol 27 (28) ◽  
pp. 3744-3753 ◽  
Author(s):  
Kawsar R. Talaat ◽  
Ruth A. Karron ◽  
Karen A. Callahan ◽  
Catherine J. Luke ◽  
Susan C. DiLorenzo ◽  
...  
Keyword(s):  
Influenza Virus ◽  
Phase I ◽  
Virus Vaccine ◽  
Phase I Trial ◽  
Influenza Virus Vaccine ◽  
Healthy Adults

Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18–64 years of age

Vaccine ◽  
2013 ◽  
Vol 31 (19) ◽  
pp. 2358-2365 ◽  
Author(s):  
Geoffrey J. Gorse ◽  
Ann R. Falsey ◽  
John A. Fling ◽  
Terry L. Poling ◽  
Cynthia B. Strout ◽  
...  
Keyword(s):  
Influenza Virus ◽  
Virus Vaccine ◽  
Influenza Virus Vaccine ◽  
Healthy Adults

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

Vaccine ◽  
2002 ◽  
Vol 20 (7-8) ◽  
pp. 1240-1247 ◽  
Author(s):  
Scott A Halperin ◽  
Bruce Smith ◽  
Taoufik Mabrouk ◽  
Marc Germain ◽  
Pierre Trépanier ◽  
...  
Keyword(s):  
Cell Culture ◽  
Influenza Vaccine ◽  
Mammalian Cell ◽  
Mammalian Cell Culture ◽  
Healthy Adults
Sign in / Sign up

Export Citation Format

Share Document